BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Freitas LF, Ferreira AH, Thipe VC, Varca GHC, Lima CSA, Batista JGS, Riello FN, Nogueira K, Cruz CPC, Mendes GOA, Rodrigues AS, Sousa TS, Alves VM, Lugão AB. The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers. Nanomaterials (Basel) 2021;11:2579. [PMID: 34685018 DOI: 10.3390/nano11102579] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Kavvadas E. C3d(g), iron nanoparticles, hemin and cytochrome c may induce oxidative cytotoxicity in tumors and reduce tumor-associated myeloid cells-mediated immunosuppression. Medical Hypotheses 2022;167:110944. [DOI: 10.1016/j.mehy.2022.110944] [Reference Citation Analysis]
2 Barchi JJ Jr. Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates. Front Immunol 2022;13:852147. [PMID: 35432351 DOI: 10.3389/fimmu.2022.852147] [Reference Citation Analysis]
3 Leroux MM, Hocquel R, Bourge K, Kokot B, Kokot H, Koklič T, Štrancar J, Ding Y, Kumar P, Schmid O, Rihn BH, Ferrari L, Joubert O. Aerosol-Cell Exposure System Applied to Semi-Adherent Cells for Aerosolization of Lung Surfactant and Nanoparticles Followed by High Quality RNA Extraction. Nanomaterials (Basel) 2022;12:1362. [PMID: 35458071 DOI: 10.3390/nano12081362] [Reference Citation Analysis]
4 Pierce KM, Miklavcic WR, Cook KP, Hennen MS, Bayles KW, Hollingsworth MA, Brooks AE, Pullan JE, Dailey KM. The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors. Nanomaterials (Basel) 2021;11:3018. [PMID: 34835785 DOI: 10.3390/nano11113018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]